Michael D.

Michael D. is a Principal Machine Learning Scientist at Iambic Therapeutics, where they lead the development of deep learning architectures for predicting clinical trial outcomes. They co-founded and directed BASH: Biodigester-Aided Solutions in Haiti, and served as a Graduate Student Researcher in Bioengineering at Stanford University, focusing on biomarker modeling for neurological diseases. Michael earned several degrees, including a Master of Science in Bioengineering from Stanford University and Bachelor’s Degrees in Chemical Engineering and Biotechnology from the University of Massachusetts Lowell. They have also held various roles across top institutions, including Genentech and Biogen, contributing to advancements in biotechnology and machine learning.